Annual EBITDA
-$44.94M$162.70M+78.36%
Summary
- Current Value
- As of today, CLOV annual EBITDA is -$44.94M, up +78.36% on
- Historical Performance
- CLOV annual EBITDA is up +92.11% over the past 3 years, and up +86.14% over the past 5 years
- All-Time High Comparison
- CLOV annual EBITDA is currently at its all-time high
- 3-Year Low Comparison
- CLOV annual EBITDA is +82.17% above its 3-year low of -$252.03M reached on an earlier date
- Sector Comparison
- CLOV annual EBITDA is higher than 32.46% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | -$44.94M | +78.4% | +92.1% | +86.1% | +86.1% | |
| Quarterly EBITDA | -$23.97M | -183.8% | +67.8% | -190.2% | -10000.0% | |
| TTM EBITDA | -$56.08M | +37.9% | +87.2% | -281.6% | -10000.0% | |
| Price | $2.54 | -29.4% | +151.5% | -84.1% | – | |
| PE Ratio | - | – | – | – | – | |
| Annual Revenue | $1.37B | +9.2% | -10.9% | +100.0% | +100.0% | |
| Annual EPS | -$0.09 | +80.2% | +93.8% | -10000.0% | -10000.0% | |
| Annual EBIT | -$46.27M | +78.0% | +91.9% | +85.8% | +85.8% | |
| Annual Net Income | -$46.27M | +78.0% | +92.1% | -10000.0% | -10000.0% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | -$44.94M | at high | |
| 5Y | -$44.94M | at high | |
| All | -$44.94M | at high |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$252.03M | N/A | +82.2% |
| 5Y | -$569.60M | +92.1% | |
| All | -$569.60M | +92.1% |
EBITDA History
| Year | Value | Change |
|---|---|---|
| -$44.94M | +78.4% | |
| -$207.63M | +17.6% | |
| -$252.03M | +55.8% |
| Year | Value | Change |
|---|---|---|
| -$569.60M | -623.5% | |
| -$78.73M | +75.7% | |
| -$324.12M | - |
FAQ
What is the current annual EBITDA of CLOV?
As of today, CLOV annual EBITDA is -$44.94M
What is 1-year change in CLOV annual EBITDA?
CLOV annual EBITDA is up +78.36% year-over-year
What is 3-year change in CLOV annual EBITDA?
CLOV annual EBITDA is up +92.11% over the past 3 years
How far is CLOV annual EBITDA from its all-time high?
CLOV annual EBITDA is currently at its all-time high
How does CLOV annual EBITDA rank versus sector peers?
CLOV annual EBITDA is higher than 32.46% of companies in Healthcare sector
When is CLOV next annual earnings release?
The next annual earnings release for CLOV is on
Quarterly EBITDA
-$23.97M$13.81M-135.82%
Summary
- Current Value
- As of today, CLOV quarterly EBITDA is -$23.97M, down -135.82% on
- Historical Performance
- CLOV quarterly EBITDA is down -183.81% year-over-year, and up +67.81% over the past 3 years
- All-Time High Comparison
- CLOV quarterly EBITDA is currently -190.21% below its historical high of $26.57M set on
- 3-Year Low Comparison
- CLOV quarterly EBITDA is +69.11% above its 3-year low of -$77.61M reached on
- Sector Comparison
- CLOV quarterly EBITDA is higher than 17.51% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | -$23.97M | -135.8% | -183.8% | +67.8% | -190.2% | |
| Annual EBITDA | -$44.94M | – | +78.4% | +92.1% | +86.1% | |
| TTM EBITDA | -$56.08M | -38.3% | +37.9% | +87.2% | -281.6% | |
| Price | $2.54 | -5.9% | -29.4% | +151.5% | -84.1% | |
| PE Ratio | - | – | – | – | – | |
| Quarterly Revenue | $496.65M | +4.0% | +50.0% | -42.0% | +128.7% | |
| Quarterly EPS | -$0.05 | -128.4% | -154.0% | +69.9% | -192.4% | |
| Quarterly EBIT | -$24.38M | -130.4% | -177.5% | +67.7% | -291.1% | |
| Quarterly Net Income | -$24.38M | -130.4% | -177.5% | +67.7% | -291.1% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$808.00K | -2866.7% | |
| 3Y | $7.50M | -419.6% | |
| 5Y | $7.50M | -419.6% | |
| All | $26.57M | -190.2% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$23.97M | at low | |
| 3Y | -$77.61M | +69.1% | |
| 5Y | -$316.26M | +92.4% | |
| All | -$316.26M | +92.4% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of CLOV?
As of today, CLOV quarterly EBITDA is -$23.97M
What is CLOV quarterly EBITDA most recent change?
CLOV quarterly EBITDA was down -135.82% on September 30, 2025
What is 1-year change in CLOV quarterly EBITDA?
CLOV quarterly EBITDA is down -183.81% year-over-year
How far is CLOV quarterly EBITDA from its all-time high?
CLOV quarterly EBITDA is currently -190.21% below its historical high of $26.57M set on September 30, 2020
How does CLOV quarterly EBITDA rank versus sector peers?
CLOV quarterly EBITDA is higher than 17.51% of companies in Healthcare sector
When is CLOV next earnings release?
The next earnings release for CLOV is on
TTM EBITDA
-$56.08M$15.53M-38.28%
Summary
- Current Value
- As of today, CLOV TTM EBITDA is -$56.08M, down -38.28% on
- Historical Performance
- CLOV TTM EBITDA is up +37.86% year-over-year, and up +87.20% over the past 3 years
- All-Time High Comparison
- CLOV TTM EBITDA is currently -281.55% below its historical high of $30.89M set on
- 3-Year Low Comparison
- CLOV TTM EBITDA is +78.04% above its 3-year low of -$255.39M reached on
- Sector Comparison
- CLOV TTM EBITDA is higher than 26.99% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | -$56.08M | -38.3% | +37.9% | +87.2% | -281.6% | |
| Annual EBITDA | -$44.94M | – | +78.4% | +92.1% | +86.1% | |
| Quarterly EBITDA | -$23.97M | -135.8% | -183.8% | +67.8% | -190.2% | |
| Price | $2.54 | -5.9% | -29.4% | +151.5% | -84.1% | |
| PE Ratio | - | – | – | – | – | |
| TTM Revenue | $1.77B | +10.3% | +32.2% | -41.3% | +215.4% | |
| TTM EPS | -$0.12 | -33.1% | +38.8% | +87.6% | +52.8% | |
| TTM EBIT | -$57.71M | -37.0% | +37.8% | +87.0% | -476.0% | |
| TTM Net Income | -$57.71M | -37.0% | +37.8% | +87.0% | -476.0% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$22.89M | -145.0% | |
| 3Y | -$22.89M | -145.0% | |
| 5Y | -$22.89M | -145.0% | |
| All | $30.89M | -281.6% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$56.08M | at low | |
| 3Y | -$255.39M | +78.0% | |
| 5Y | -$610.44M | +90.8% | |
| All | -$610.44M | +90.8% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of CLOV?
As of today, CLOV TTM EBITDA is -$56.08M
What is CLOV TTM EBITDA most recent change?
CLOV TTM EBITDA was down -38.28% on September 30, 2025
What is 1-year change in CLOV TTM EBITDA?
CLOV TTM EBITDA is up +37.86% year-over-year
How far is CLOV TTM EBITDA from its all-time high?
CLOV TTM EBITDA is currently -281.55% below its historical high of $30.89M set on September 30, 2020
How does CLOV TTM EBITDA rank versus sector peers?
CLOV TTM EBITDA is higher than 26.99% of companies in Healthcare sector
When is CLOV next earnings release?
The next earnings release for CLOV is on
EBITDA Formula
EBITDA = + + +
Data Sources & References
- CLOV Official Website www.cloverhealth.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1801170/000180117025000269/0001801170-25-000269-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1801170/000180117025000052/0001801170-25-000052-index.htm
- CLOV Profile on Yahoo Finance finance.yahoo.com/quote/CLOV
- CLOV Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/clov